Почетна › Steatotna bolest jetre › Вирџинија
Kliničke studije za Steatotna bolest jetre u državi Вирџинија
15 studija za Steatotna bolest jetre traži učesnike na lokacijama u državi Вирџинија.
Gradovi u državi Вирџинија
Zvanični tekst studije (na engleskom)
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
- GSK Investigational Site, Richmond
- GSK Investigational Site, Richmond
Тражи се учесникФаза 2
Узраст од 18 до 70 · Оба пола · Ажурирано 13. 11. 2026. · NCT06613698A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Norfolk
- Akero Clinical Study Site, Richmond
- Akero Clinical Study Site, Richmond
- и још 2
Тражи се учесникФаза 3
Узраст од 18 до 80 · Оба пола · Ажурирано 12. 11. 2026. · NCT06528314A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- GI Select Health Research, Richmond
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 9. 11. 2026. · NCT07288138A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
- GSK Investigational Site, Richmond
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 5. 11. 2026. · NCT06920043A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- GSK Investigational Site, Manassas
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 5. 11. 2026. · NCT07704892A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- GSK Investigational Site, Manassas
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 5. 11. 2026. · NCT07701993A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Richmond
- 89bio Clinical Study Site, Richmond
- 89bio Clinical Study Site, Richmond
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 23. 10. 2026. · NCT06419374A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Richmond
- 89bio Clinical Study Site, Richmond
- 89bio Clinical Study Site, Richmond
- и још 1
Тражи се учесникФаза 3
Узраст од 18 до 80 · Оба пола · Ажурирано 23. 10. 2026. · NCT06318169A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- Eximia Research - Norfolk, Norfolk
- Richmond Veterans Affairs Medical Center (Richmond VA Medical Center), Richmond
- Virginia Commonwealth University (VCU) Medical Center, Richmond
- и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07165028Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
- Virginia Commonwealth University, Richmond
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 28. 9. 2026. · NCT05832229A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
- GSK Investigational Site, Manassas
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 17. 9. 2026. · NCT07221188A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
- GSK Investigational Site, Manassas
- GSK Investigational Site, Norfolk
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 27. 7. 2026. · NCT07221227Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant
- Virginia Commonwealth University, Richmond
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 4. 6. 2026. · NCT05424003Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
- University of Virginia, Charlottesville
- Virginia Common wealth University, Richmond
Тражи се учесник
Узраст од 18 до 75 · Оба пола · Ажурирано 19. 5. 2026. · NCT04054310Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced Fibrosis
- Virginia Commonwealth University, Richmond
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 2. 4. 2026. · NCT05720663Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.